IP Library Patent Application 11337996
Patent Application
App. No. 11/337,996

Medical device with antimicrobial layer

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/337,996
Abstract

A medical device includes a conduit for a fluid. The conduit has a wall formed of a hydrophobic polymer with a hydrophilic polymer layer extruded over it, and an antimicrobial substantially dispersed within the hydrophilic polymer. The antimicrobial compound may be a predetermined amount of phosphorus-based glass having a predetermined quantity of a metal such as silver substantially dispersed therein. The medical device may be an endotracheal tube made by providing a hydrophobic polymer, a hydrophilic polymer and an antimicrobial compound, forming the hydrophobic polymer, the hydrophilic polymer and the antimicrobial compound into a conduit, and forming a cuff on an end of the conduit.

Claims (105)

1 . A method of making a medical device wall, the method comprising:

providing a hydrophobic polymer;

extruding the hydrophobic polymer to form a medical device wall;

providing an antimicrobial compound comprising a predetermined amount of water-soluble glass having a predetermined quantity of metal substantially dispersed therein;

mixing the antimicrobial compound and a hydrophilic polymer; and

extruding a layer of the hydrophilic polymer having the antimicrobial compound substantially dispersed therein over at least a portion of a surface of the wall.

2 . The method, as set forth in claim 1 , wherein the metal comprises copper, gold, silver, zinc, magnesium, boron, iodine, manganese, selenium, chromium, allium or a combination thereof.

3 . The method, as set forth in claim 1 , wherein the metal comprises substantially elemental metal, metal ions, metal oxide or a combination thereof.

4 . The method, as set forth in claim 1 , wherein the hydrophobic polymer comprises a conduit.

5 . The method, as set forth in claim 4 , wherein the layer is extruded onto an inner surface of the conduit, an outer surface of the conduit, or both.

6 . The method, as set forth in claim 4 , comprising:

providing a cuff on an end of the conduit.

7 . The method, as set forth in claim 6 , wherein the layer is extruded onto at least a portion of the cuff or the conduit.

8 . The method, as set forth in claim 1 , wherein the antimicrobial compound and the hydrophobic polymer are co-extruded.

9 . The method, as set forth in claim 1 , wherein the layer is between 0.002 mm-2.5 mm in thickness.

10 . The method, as set forth in claim 1 , wherein the hydrophilic polymer comprises polyurethane.

11 . The method, as set forth in claim 1 , wherein the hydrophilic polymer comprises medical grade hydrophilic thermoplastic polyurethane.

12 . The method, as set forth in claim 1 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of up to about 0.01 μ-grams/cm 2 /day.

13 . The method, as set forth in claim 1 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of between about 0.01 and about 1.0 μ-grams/cm 2 /day.

14 . The method, as set forth in claim 1 , wherein the metal is adapted to be released from the phosphorous-based at an elution rate of about 0.4 μ-grams/cm 2 /day.

15 . The method, as set forth in claim 1 , wherein the water-soluble glass comprises about 0.1-50% by weight of the antimicrobial compound.

16 . The method, as set forth in claim 1 , wherein the hydrophobic polymer comprises polyvinyl chloride, polyethylene, polyurethane, polydimethylsiloxane, polyester, silicone, or rubber.

17 . The method, as set forth in claim 1 , comprising forming an endotracheal tube comprising the medical device wall.

18 . The method, as set forth in claim 1 , comprising mixing the antimicrobial compound and a hydrophilic polymer with an indicator of carbon dioxide concentration, a bronchodilator, an anti-inflammatory agent, or a local anesthetic.

19 . A method comprising:

providing a medical device comprising a hydrophobic polymer;

providing a mixture comprising a hydrophilic polymer and a water-soluble glass, wherein the water-soluble glass has a quantity of metal substantially dispersed therein; and

extruding a layer of the mixture over at least a portion of the hydrophobic polymer.

20 . The method, as set forth in claim 19 , wherein the metal comprises copper, gold, silver, zinc, magnesium, boron, iodine, manganese, selenium, chromium, allium or a combination thereof.

21 . The method, as set forth in claim 19 , wherein the metal comprises substantially elemental metal, metal ions, metal oxide or a combination thereof.

22 . The method, as set forth in claim 19 , wherein the hydrophobic polymer comprises a conduit.

23 . The method, as set forth in claim 22 , wherein the mixture is extruded onto an inner surface of the conduit, an outer surface of the conduit, or both.

24 . The method, as set forth in claim 22 , comprising:

providing a cuff on an end of the conduit.

25 . The method, as set forth in claim 24 , wherein the mixture is extruded onto at least a portion of the cuff or the conduit.

26 . The method, as set forth in claim 19 , wherein the mixture and the hydrophobic polymer are co-extruded.

27 . The method, as set forth in claim 19 , wherein the layer is between 0.002 mm-2.5 mm in thickness.

28 . The method, as set forth in claim 19 , wherein the water-soluble glass comprises a phosphorous-based glass.

29 . The method, as set forth in claim 19 , wherein the hydrophilic polymer comprises polyurethane.

30 . The method, as set forth in claim 19 , wherein the hydrophilic polymer comprises medical grade hydrophilic thermoplastic polyurethane.

31 . The method, as set forth in claim 19 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of up to about 0.01 μ-grams/cm 2 /day.

32 . The method, as set forth in claim 19 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of between about 0.01 and about 1.0 μ-grams/cm 2 /day.

33 . The method, as set forth in claim 19 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of about 0.4 μ-grams/cm 2 /day.

34 . The method, as set forth in claim 19 , wherein the water-soluble glass comprises about 0.1-50% by weight of the mixture.

35 . The method, as set forth in claim 19 , wherein the hydrophobic polymer comprises polyvinyl chloride, polyethylene, polyurethane, polydimethylsiloxane, polyester, silicone, or rubber.

36 . The method, as set forth in claim 19 , wherein the medical device comprises an endotracheal tube.

37 . The method, as set forth in claim 19 , wherein the mixture comprises an indicator of carbon dioxide concentration, a bronchodilator, an anti-inflammatory agent, or a local anesthetic.

38 . A medical device comprising:

a hydrophobic polymer substrate, and

an extrusion covering at least a portion of the hydrophobic polymer substrate, the extrusion comprising a hydrophilic polymer and a water-soluble glass, wherein the water-soluble glass has a quantity of metal substantially dispersed therein.

39 . The medical device, as set forth in claim 38 , wherein the metal comprises copper, gold, silver, zinc, magnesium, boron, iodine, manganese, selenium, chromium, allium or a combination thereof.

40 . The medical device, as set forth in claim 38 , wherein the metal comprises substantially elemental metal, metal ions, metal oxide or a combination thereof.

41 . The medical device, as set forth in claim 38 , wherein the hydrophobic polymer comprises a conduit.

42 . The medical device, as set forth in claim 41 , wherein the extrusion is disposed on an inner surface of the conduit, an outer surface of the conduit, or both.

43 . The medical device, as set forth in claim 41 , wherein the conduit comprises a cuff.

44 . The medical device, as set forth in claim 43 , wherein the extrusion is disposed on at least a portion of the cuff.

45 . The medical device, as set forth in claim 38 , comprising a co-extruded hydrophobic polymer.

46 . The medical device, as set forth in claim 38 , wherein the extrusion is between 0.002 mm-2.5 mm in thickness.

47 . The medical device, as set forth in claim 38 , wherein the water-soluble glass comprises a phosphorous-based glass.

48 . The medical device, as set forth in claim 38 , wherein the hydrophilic polymer comprises polyurethane.

49 . The medical device, as set forth in claim 38 , wherein the hydrophilic polymer comprises medical grade hydrophilic thermoplastic polyurethane.

50 . The medical device, as set forth in claim 38 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of up to about 0.01 μ-grams/cm 2 /day.

51 . The medical device, as set forth in claim 38 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of between about 0.01 and about 1.0 μ-grams/cm 2 /day.

38 . The medical device, as set forth in claim 38 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of about 0.4 μ-grams/cm 2 /day.

53 . The medical device, as set forth in claim 38 , wherein the water-soluble glass comprises about 0.1-50% by weight of the mixture.

54 . The medical device, as set forth in claim 38 , wherein the hydrophobic polymer comprises polyvinyl chloride, polyethylene, polyurethane, polydimethylsiloxane, polyester, silicone, or rubber.

55 . The medical device, as set forth in claim 38 , wherein the medical device comprises an endotracheal tube.

56 . The medical device, as set forth in claim 38 , wherein the extrusion comprises an indicator of carbon dioxide concentration, a bronchodilator, an anti-inflammatory agent, or a local anesthetic.

57 . The medical device, as set forth in claim 38 , comprising a ventilation device operatively connected to the medical device.

58 . A medical device comprising:

a device wall, wherein at least a portion of the device wall is an extrusion, the extrusion being formed from a mixture comprising a hydrophobic polymer substrate, a hydrophilic polymer and a water-soluble glass, wherein the water-soluble glass has a quantity of metal substantially dispersed therein.

59 . The medical device, as set forth in claim 58 , wherein the metal comprises copper, gold, silver, zinc, magnesium, boron, iodine, manganese, selenium, chromium, allium or a combination thereof.

60 . The medical device, as set forth in claim 58 , wherein the metal comprises substantially elemental metal, metal ions, metal oxide or a combination thereof.

61 . The medical device, as set forth in claim 58 , wherein the medical device comprises a conduit.

62 . The medical device, as set forth in claim 58 , wherein the conduit comprises a cuff.

63 . The medical device, as set forth in claim 58 , wherein the water-soluble glass comprises a phosphorous-based glass.

64 . The medical device, as set forth in claim 58 , wherein the hydrophilic polymer comprises polyurethane.

65 . The medical device, as set forth in claim 58 , wherein the hydrophilic polymer comprises medical grade hydrophilic thermoplastic polyurethane.

66 . The medical device, as set forth in claim 58 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of up to about 0.01 μ-grams/cm 2 /day.

67 . The medical device, as set forth in claim 58 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of between about 0.01 and about 1.0 μ-grams/cm 2 /day.

68 . The medical device, as set forth in claim 58 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of about 0.4 μ-grams/cm 2 /day.

69 . The medical device, as set forth in claim 58 , wherein the water-soluble glass comprises about 0.1-50% by weight of the compounded mixture.

70 . The medical device, as set forth in claim 58 , wherein the hydrophobic polymer comprises polyvinyl chloride, polyethylene, polyurethane, polydimethylsiloxane, polyester, silicone, or rubber.

71 . The medical device, as set forth in claim 58 , wherein the medical device comprises an endotracheal tube.

72 . The medical device, as set forth in claim 58 , wherein the medical device comprises an indicator of carbon dioxide concentration, a bronchodilator, an anti-inflammatory agent, or a local anesthetic.

73 . The medical device, as set forth in claim 58 , comprising a ventilation device operatively connected to the medical device.

74 . An endotracheal cuff comprising:

a hydrophobic polymer substrate, and

an extrusion covering at least a portion of the hydrophobic polymer substrate, the extrusion comprising a hydrophilic polymer and a water-soluble glass, wherein the water-soluble glass has a quantity of metal substantially dispersed therein.

75 . The endotracheal cuff, as set forth in claim 74 wherein the metal comprises copper, gold, silver, zinc, magnesium, boron, iodine, manganese, selenium, chromium, allium or a combination thereof.

76 . The endotracheal cuff, as set forth in claim 74 , wherein the metal comprises substantially elemental metal, metal ions, metal oxide or a combination thereof.

77 . The endotracheal cuff, as set forth in claim 74 , comprising a conduit.

78 . The endotracheal cuff, as set forth in claim 74 , comprising a co-extruded hydrophobic polymer.

79 . The endotracheal cuff, as set forth in claim 74 , wherein the extrusion is between 0.002 mm-2.5 mm in thickness.

80 . The endotracheal cuff, as set forth in claim 74 , wherein the water-soluble glass comprises a phosphorous-based glass.

81 . The endotracheal cuff, as set forth in claim 74 , wherein the hydrophilic polymer comprises polyurethane.

82 . The endotracheal cuff, as set forth in claim 74 , wherein the hydrophilic polymer comprises medical grade hydrophilic thermoplastic polyurethane.

83 . The endotracheal cuff, as set forth in claim 74 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of up to about 0.01 μ-grams/cm 2 /day.

84 . The endotracheal cuff, as set forth in claim 74 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of between about 0.01 and about 1.0 μ-grams/cm 2 /day.

85 . The endotracheal cuff, as set forth in claim 74 , wherein the metal is adapted to be released from the water-soluble glass at an elution rate of about 0.4 μ-grams/cm 2 /day.

86 . The endotracheal cuff, as set forth in claim 74 , wherein the water-soluble glass comprises about 0.1-50% by weight of the mixture.

87 . The endotracheal cuff, as set forth in claim 74 , wherein the hydrophobic polymer comprises polyvinyl chloride, polyethylene, polyurethane, polydimethylsiloxane, polyester, silicone, or rubber.

88 . The endotracheal cuff, as set forth in claim 74 , comprising an endotracheal tube.

89 . The endotracheal cuff, as set forth in claim 74 , wherein the extrusion comprises an indicator of carbon dioxide concentration, a bronchodilator, an anti-inflammatory agent, or a local anesthetic.

90 . The endotracheal cuff, as set forth in claim 74 , comprising a ventilation device operatively connected to the endotracheal cuff by a conduit.